No, it’s actually the opposite. The risk of addiction to psilocybin, the active ingredient in our microdose, is minimal at 0.2%. For comparison, the risk for SSRIs is 44%. Ongoing research is currently exploring psilocybin as a potential treatment for substance use disorders. Nevertheless, it’s always important to monitor your relationship with it.